One of the important problems of the patients undergoing acute myocardial infarction (MI) is
early development of heart failure. It has been revealed in various studies that renin …

The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …

Heart failure which occurs due to various causes including primarily coronary artery
diseases and hypertension is a syndrome with complex physiopathology and clinic that can …

Left ventricular (LV) dysfunction and/or heart failure (HF) are frequent complications of
hypertension and myocardial infarction (MI), placing affected patients at increased risk of …

Valsartan in acute myocardial infarction trial. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

Background Survivors of acute myocardial infarction (MI) complicated by heart failure and/or
resulting in left ventricular dysfunction are at heightened risk for subsequent death and …

Survivors of myocardial infarction (MI) are at high risk of disability and death. This is due to
infarct-related complications such as heart failure, cardiac remodeling with progressive …

Abstract Abstract Valsartan (Diovan®) is an oral angiotensin II-receptor antagonist with
specificity for the angiotensin II type 1 receptor subtype. It demonstrates antihypertensive …

Angiotensin-converting enzyme inhibitors (ACE-Is) are an evidence-based treatment for
patients who after myocardial infarction (MI) present with either heart failure (HF) or left …

Blockade of the renin–angiotensin system by angiotensin converting enzyme (ACE)
inhibitors reduces mortality and morbidity in patients post-myocardial infarction as well as in …